【摘要】 目的研究分析阿卡波糖在2型糖尿病强化治疗中的应用方法和效果。方法回顾性分析2010年1月至2012年12月期间,我院收治并采用皮下注射胰岛素强化治疗的104例2型糖尿病患者的临床资料,按照患者强化治疗后采用的不同治疗方式,将104例患者随机分为两组,观察组52例,采用甘精胰岛素联合阿卡波糖治疗,对照组52例,采用单一甘精胰岛素治疗。比较两组患者治疗12周后的血糖水平及血红蛋白变化。结果治疗后观察组与对照组患者的餐前、餐后血糖水平变化及血红蛋白变化情况比较存在明显差异,差异具有统计学意义(P<0.05);两组患者的低血糖发生率比较差异无统计学意义(P>0.05)。结论 2型糖尿病患者强化治疗后采用甘精胰岛素联合阿卡波糖治疗能够提高患者的治疗依从性,疗效显著,安全性高,值得临床推广。更多还原

【Abstract】 Objective To discuss the methods and effect of treating type 2 diabetes with acarbose in intensive therapy.Methods Choosed 104 patients of type 2 diabetes from Jan.2010 to Dec.2012 to treat with intensive therapy to divide into study group and controlled group with 52 cases in each other.The study group were treated with insulin glargine combined acarbose,and controlled group were treated with insulin glargine only.Compared the level of blood glucose and changing of hemoglobin.Results The changing of level of blood glucose before and after meal had significant difference(P<0.05).There was no significant difference in incidence of hypoglycemia in these two groups(P<0.05).Conclusion Treating type 2 diabetes with acarbose in intensive therapy could increase patients’ compliance and safety to extend in clinic.更多还原